Bahl & Gaynor’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.04M Buy
7,020
+870
+14% +$264K 0.01% 196
2026
Q1
$1.31M Buy
6,150
+650
+12% +$145K 0.01% 220
2025
Q4
$941K Hold
5,500
– – ﹤0.01% 241
2025
Q3
$736K Sell
5,500
-102
-2% -$10.8K ﹤0.01% 254
2025
Q2
$545K Buy
5,602
+102
+2% +$8.09K ﹤0.01% 277
2025
Q1
$400K Hold
5,500
– – ﹤0.01% 300
2024
Q4
$397K Hold
5,500
– – ﹤0.01% 296
2024
Q3
$449K Buy
+5,500
New +$478K ﹤0.01% 290

Other funds holding LRCX

Bahl & Gaynor's LRCX Position: Q2 2026 in Review

Bahl & Gaynor increased its Lam Research (LRCX) stake by 14% in Q2 2026, buying an estimated $264K and bringing the position to 7,020 shares worth $3.04M. The position accounts for 0.01% of the portfolio, ranked #196.

Bahl & Gaynor first reported a position in LRCX in Q3 2024 and has held it in 8 quarters since. 3,146 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

  • Bahl & Gaynor held 7,020 shares of Lam Research worth $3.04M as of Q2 2026.
  • Bahl & Gaynor bought 870 Lam Research shares in Q2 2026, an estimated $264K.
  • Lam Research made up 0.01% of Bahl & Gaynor's portfolio in Q2 2026, its #196 holding.
  • Bahl & Gaynor first reported a position in Lam Research in Q3 2024 and has held it in 8 quarters since.
  • 3,146 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Bahl & Gaynor's 13F filing for Q2 2026, filed 13 Aug 2026.